ConductScience.org, home

Trial · NCT00590018

Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease

NCT00590018, Phase 2, Completed, Baylor College of Medicine; results first posted 2016-05-26

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease. Trials, record NCT00590018. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00590018

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease
NCT number
NCT00590018
Status
Completed
Phases
Phase 2
Enrollment
18 participants, actual
Lead sponsor
Baylor College of Medicine
Conditions
Cardiac Output, Low
Interventions
Hydrocortisone, Placebo
First posted
2008-01-10
Last updated
2016-05-26
Results first posted
2016-05-26

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBlood Pressure.2 daysChange in mean blood pressure recorded prior to (15 minutes prior to study drug) and subsequent to medication/placebo administration (at 2 days post drug administration).
SecondaryChange in Inotrope Score. This is the Change in the Inotrope Score Between 15 Minutes Prior to Drug Administration and at 2 Days After Drug Administration.2 days
Inotrope score: epinephrine (mcg/kg/min x 100) + norepinephrine (mcg/kg/min x 100) + phenylephrine (mcg/kg/min x 100) + dopamine (mcg/kg/min x1) + dobutamine (mcg/kg/min x 1) + milrinone (mcg/kg/min x15). A lower inotrope score is better with the minimum being 0 and the maximum being 85.

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYBlood Pressure.2 daysmmHgMEAN
SECONDARYChange in Inotrope Score. This is the Change in the Inotrope Score Between 15 Minutes Prior to Drug Administration and at 2 Days After Drug Administration.2 daysunits on a scaleMEAN

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Blood Pressure.Hydrocortisone6Standard Deviation 7.86mmHg
Blood Pressure.Placebo5.89Standard Deviation 9.24mmHg
Change in Inotrope Score. This is the Change in the Inotrope Score Between 15 Minutes Prior to Drug Administration and at 2 Days After Drug Administration.Hydrocortisone8.83Standard Deviation 9.61units on a scale
Change in Inotrope Score. This is the Change in the Inotrope Score Between 15 Minutes Prior to Drug Administration and at 2 Days After Drug Administration.Placebo7.17Standard Deviation 4.8units on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDHydrocortisone9
Overall StudySTARTEDPlacebo9
Overall StudyCOMPLETEDHydrocortisone9
Overall StudyCOMPLETEDPlacebo9
Overall StudyNOT COMPLETEDHydrocortisone0
Overall StudyNOT COMPLETEDPlacebo0

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousDeathCardiac disordersHydrocortisone090
seriousDeathCardiac disordersPlacebo191

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityHydrocortisone
Total, all-cause mortalityPlacebo
Total, other adverse eventsHydrocortisone09
Total, other adverse eventsPlacebo09
Total, serious adverse eventsHydrocortisone09
Total, serious adverse eventsPlacebo19

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
16276331BACKGROUNDPubMed
33045104DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Hydrocortisone vs Placebo: serious adverse events

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00590018

GET https://conductscience.org/api/trials/v1/NCT00590018/registered